SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-079796
Filing Date
2014-11-12
Accepted
2014-11-12 16:30:46
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-19694_110q.htm 10-Q 936260
2 EX-31.1 a14-19694_1ex31d1.htm EX-31.1 10500
3 EX-31.2 a14-19694_1ex31d2.htm EX-31.2 10506
4 EX-32.1 a14-19694_1ex32d1.htm EX-32.1 7496
5 EX-32.2 a14-19694_1ex32d2.htm EX-32.2 7515
  Complete submission text file 0001104659-14-079796.txt   5907541

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT supn-20140930.xml EX-101.INS 971199
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20140930.xsd EX-101.SCH 31371
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20140930_cal.xml EX-101.CAL 60011
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20140930_def.xml EX-101.DEF 101403
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT supn-20140930_lab.xml EX-101.LAB 354719
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20140930_pre.xml EX-101.PRE 241603
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 141214490
SIC: 2834 Pharmaceutical Preparations